Journal
BIOMACROMOLECULES
Volume 20, Issue 10, Pages 3778-3785Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.biomac.9b00849
Keywords
-
Funding
- National Institutes of Health [R03AI142420-01]
- Oklahoma Center of Advancement of Science and Technology [HR16-084-3]
- University of Oklahoma
Ask authors/readers for more resources
Microbial biofilms are ubiquitous in nature, and they pose a serious threat to public health. Staphylococcus epidermidis is the most common clinical isolate from healthcare- and medical device-related biofilm infections. No antibiotic currently on the market can eradicate pathogenic biofilms, which contain complex defense mechanisms composed of slimelike extracellular polymeric substances. Understanding the need to develop alternative approaches, we examine 600 Da branched polyethylenimine (BPEI) against methicillin-resistant Staphylococcus epidermidis (MRSE) biofilms. Here, a microtiter biofilm model is used to test the synergistic effects between the two components of our combination treatment: BPEI and beta-lactam antibiotics. Electron microscopy was used to confirm the growth of MRSE biofilms from the model. Minimum biofilm eradication concentration assays, crystal violet assays, and biofilm kill curves suggest that BPEI exhibits antibiofilm activity and can potentiate beta-lactams to eradicate MRSE biofilms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available